Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Current therapies for the soluble lysosomal forms of neuronal ceroid lipofuscinosis.

Biochemical Society transactions - 1 Dec 2010

Wong Andrew M S, Rahim Ahad A, Waddington Simon N, Cooper Jonathan D

Abstract excerpt

The NCLs (neuronal ceroid lipofuscinoses) are the most common inherited paediatric neurodegenerative disorder. Although genetically distinct, NCLs can be broadly divided into two categories: one in which the mutation results in a defect in a transmembrane protein, and the other where the defect l...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Endocytosis
Share to Enzyme Replacement Therapy
Share to Genetic Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lysosomes

Share to Molecular Chaperones

Share to Neuronal Ceroid-Lipofuscinoses

Share to Receptor, IGF Type 2

Share to Stem Cell Transplantation

Source

Identifiers

PMID: 21118112
DOI: 10.1042/BST0381484

Genes

NCL

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-21118112-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Current therapies for the soluble lysosomal forms of neuronal ceroid lipofuscinosis.PMID 21118112Read ↗

Progress in gene and cell therapies for the neuronal ceroid lipofuscinoses.Semantic proximity Read ↗

Neuronal Ceroid Lipofuscinosis—Concepts, Classification, and Avenues for TherapySemantic proximity Read ↗

Therapeutic approaches to the challenge of neuronal ceroid lipofuscinoses.Semantic proximity Read ↗

Gene-Based Approaches to Inherited Neurometabolic DiseasesSemantic proximity Read ↗

Recent Insight into the Genetic Basis, Clinical Features, and Diagnostic Methods for Neuronal Ceroid Lipofuscinosis.Semantic proximity Read ↗

Classification and natural history of the neuronal ceroid lipofuscinoses.Semantic proximity Read ↗

Neuronal ceroid lipofuscinosis: impact of recent genetic advances and expansion of the clinicopathologic spectrum.Semantic proximity Read ↗

Pathogenesis and therapies for infantile neuronal ceroid lipofuscinosis (infantile CLN1 disease).Semantic proximity Read ↗

Towards understanding the neuronal ceroid lipofuscinoses.Semantic proximity Read ↗

The neuronal ceroid-lipofuscinoses: from past to present.Semantic proximity Read ↗

Pathomechanisms in the neuronal ceroid lipofuscinoses.Semantic proximity Read ↗

Gene therapy for lysosomal storage disorders: a good startSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.